Review of Oral Propranolol Therapy for Infantile Hemangioma

Authors

  • Theresia Risa Davita Mondrian Clinic, Central Java
  • Aditya Dewanto Hendrani LSU Health Center, Shreveport

DOI:

https://doi.org/10.37591/rrjos.v8i1.717

Abstract

Infantile hemangioma, or called as strawberry hemangioma, is the most common vascular tumor in infancy. Although most will resolve, the rest of IHs are significantly worrisome; some can ulcerate or even grow at an unpredictable rate, which leads to disfigurement and dysfunctional body parts. The treatment should be focused on prevention of life-threatening complications, prevention of permanent scarring, and avoidance of aggressive treatments; these are the goals of management. This review article is made to increase the awareness of using oral propranolol as a choice of nonsurgical therapy, especially for countries where surgery is not an option.

 

Keywords: infantile hemangioma, propranolol, beta-blocker, tumor.


Cite this Article

Davita TR, Hendrani AD. Review of Oral Propranolol Therapy for Infantile Hemangioma. Research & Reviews: Journal of Surgery. 2019; 8(1): 25–29p.


Author Biographies

Theresia Risa Davita, Mondrian Clinic, Central Java

Medical Doctor

Aditya Dewanto Hendrani, LSU Health Center, Shreveport

Cardiology Department

Published

2019-05-01

Issue

Section

Review Article